US Patent 11977081 ANGPTL8 assay and uses thereof
Patent 11977081 was granted and assigned to Regeneron Pharmaceuticals on May, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+19 properties)
Article (+159 characters)
US Patent 11977081 ANGPTL8 assay and uses thereof
Article
Patent abstract
The present invention provides ELISA-based methods for detecting and/or quantifying ANGPTL8 in biological samples using anti-ANGPTL8 antibodies.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andrew J. Murphy0
Jesper Gromada0
Viktoria Gusarova0
Date of Patent
May 7, 2024
0Patent Application Number
169549180
Date Filed
December 18, 2018
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11977081 ANGPTL8 assay and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
